$3.84
Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
What This MannKind Filing Reveals About Three Years of Underperformance
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk
What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million
Overview
52-week range
$2.23
$6.51
38% of range
Avg surprise (last 3)
-72.2%
Avg reaction (last 2)
+10.0%
50% positive
Latest IV / EM
287%
EM ±16.9% · $4 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.05 | $-0.02 | -150.0% | -225.0% | +24.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.03 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | — | $0.04 | -100.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.04 | $0.03 | +33.3% | — | -4.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.01 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.01 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.02 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | -$0.02 | — |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $90M | — | $82M | $77M | $78M | — | $70M | $72M |
| Cost of revenue | $8M | — | $4M | $5M | $4M | — | $3M | $6M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | — | $19M | $5M | $22M | — | $13M | $17M |
| Net income | $-17M | — | $8M | $668,000 | $13M | — | $12M | $-2M |
| EPS (diluted) | $-0.05 | — | $0.03 | — | $0.04 | — | $0.04 | $-0.01 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M |
| Inventory | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M |
| Total current assets | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M |
| Total assets | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M |
| Total equity | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M |